JESUS ANTONIO LARA REYES

Dr. JESUS ANTONIO LARA REYES

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in MethodsX
Verified
Journal Article
Open access
JRJESUS ANTONIO LARA REYES
JESUS ANTONIO LARA REYES
MJMariana Giezi Jimenez-Buendia
Mariana Giezi Jimenez-Buendia
GAGonzalo Aranda-Abreu
Gonzalo Aranda-Abreu
Deissy Herrera-CovarrubiasDeissy Herrera-Covarrubias
Deissy Herrera-Covarrubias
CSClara Luz Sampieri
Clara Luz Sampieri
FRFausto Rojas-Durán
Fausto Rojas-Durán
Cell migration is the process by which cells move through tissues, and it is crucial to carry out a wide variety of physiological and pathological processes. The study methods to evaluate cell migration are very useful tools for biomedical research. Among these methods, the wound and healing assay is one of the simplest, most economical and is widely used in research. However, one of its disadvantages is that the width and shape of the wound can vary among experimental samples since the scraping is carried out manually, representing a difficult variable to control. In the present article a variant of the razor scrape assay is addressed, which eliminates this variation in the width of the wound, thus facilitating the measurement and comparison using the total area of cell migration.•A method that can be carried out under standard culture conditions.•Avoids the disadvantage of variation in width and shape of the wound.•It constitutes a simple, cheap option and multiple advantages over the traditional method.

6 February 2026 in Neurology International
Verified
Journal Article
Open access
PDF file
JRJESUS ANTONIO LARA REYES
JESUS ANTONIO LARA REYES
Cristofer Zarate-CalderonCristofer Zarate-Calderon
Cristofer Zarate-Calderon
GAGonzalo Aranda-Abreu
Gonzalo Aranda-Abreu
Luis I. GarcíaLuis I. García
Luis I. García
FRFausto Rojas-Durán
Fausto Rojas-Durán
Background: Neuropathic pain represents a substantial global burden with limited effective therapeutic options. Pulsed Electromagnetic Field (PEMF) therapy has emerged as a potential non-invasive adjuvant, though clinical evidence remains inconsistent. This systematic review and meta-analysis evaluated PEMF efficacy and safety, specifically analyzing the influence of etiology and stimulation parameters. Methods: Following PRISMA 2020 guidelines (PROSPERO: CRD420251184151), five databases (Cochrane, PubMed, Scopus, Web of Science, and LILACS) were searched for Randomized Controlled Trials (RCTs) comparing PEMF versus sham. Risk of bias was assessed via Cochrane RoB 2, and heterogeneity was explored through detailed subgroup analyses. Results: Thirteen RCTs met the inclusion criteria (N = 688). While global analysis indicated a statistically significant pain reduction (SMD: −1.01; p = 0.03), it exhibited extreme statistical heterogeneity (I2 = 92.8%) and instability. After adjusting for missing studies using the Trim-and-Fill method, global significance disappeared. However, subgroup analysis resolved this inconsistency, revealing a massive, clinically meaningful effect in Spinal/Radicular pain (SMD: −2.35; 95% CI: −4.42 to −0.29), whereas Peripheral Neuropathy showed no significant reduction (SMD: −0.38; 95% CI: −0.86 to 0.10). Conclusions: The PEMF evidence base for neuropathic pain is currently highly fragmented. Extreme heterogeneity and publication bias render “one-size-fits-all” efficacy estimates invalid and potentially misleading. Instead, our data reveals a critical etiological divergence: PEMF appears highly effective for spinal/radicular pathology, likely due to the mechanical nature of the lesion, but demonstrates limited efficacy for diffuse peripheral neuropathy. Future research must abandon generic protocols in favor of etiology-specific trials, prioritizing high-frequency parameters and rigorous bias control.

18 March 2026 in Radiation
Verified
Journal Article
Open access
PDF file
JRJESUS ANTONIO LARA REYES
JESUS ANTONIO LARA REYES
LCLibia Xamanek Cortijo-Palacios
Libia Xamanek Cortijo-Palacios
MHMaria Elena Hernandez-Aguilar
Maria Elena Hernandez-Aguilar
GAGonzalo Aranda-Abreu
Gonzalo Aranda-Abreu
FRFausto Rojas-Durán
Fausto Rojas-Durán
Cancer remains a significant global health burden, often requiring conventional treatments characterized by considerable side effects and limited tumor specificity. This review addresses the critical gap in understanding the non-thermal mechanisms by which Pulsed Electromagnetic fields (PEMFs) exert selective anti-tumor effects. Our primary objective is to analyze the molecular and cellular events through which low-intensity PEMF triggers stress responses and apoptosis in neoplastic cells without impacting normal cell viability. This comprehensive review synthesizes current evidence on the biological effects of PEMFs. Findings indicate that PEMFs disrupts intracellular homeostasis, induces reactive oxygen species-mediated oxidative stress, and activates endoplasmic reticulum stress, collectively driving malignant cells towards apoptosis or cell cycle arrest. Importantly, these effects are preferentially observed in cancer cells due to their inherent biophysical vulnerabilities—such as depolarized membrane potentials—and depend critically on specific PEMFs parameters. In conclusion, PEMFs acts as a multifaceted disruptor of cancer cell homeostasis, representing a promising non-invasive therapeutic modality. Further research is essential to optimize dosimetry and identify primary molecular sensors such as radical pair dynamics, to enhance clinical application and explore synergistic combinations with existing therapies.

21 October 2026 in Antioxidants
Verified
Journal Article
Open access
PDF file
MLManuel de Jesus Castillejos López
Manuel de Jesus Castillejos López
UBUlises Barrera-Elizalde
Ulises Barrera-Elizalde
EFEdgar Flores-Soto
Edgar Flores-Soto
LCLuz A. Colín-Godínez
Luz A. Colín-Godínez
LTLuz-María Torres-Espíndola
Luz-María Torres-Espíndola
AAArnoldo Aquino-Gálvez
Arnoldo Aquino-Gálvez
Lung adenocarcinoma (LUAD) exhibits metabolic flexibility that transcends the classical interpretation of the Warburg effect. This review proposes the concept of “adaptive mitochondrial specialization (AMS)”, an integrative framework in which mitochondria undergo coordinated, context-dependent remodeling of bioenergetic metabolism, redox homeostasis, architecture and dynamics, proteostasis, mitochondrial genome maintenance and translation, and inter-organelle communication in response to hypoxia and other tumor-associated stressors. We examine how hypoxia can promote this adaptive state through HIF-dependent metabolic reprogramming together with intrinsic mitochondrial stress responses, including respiratory-chain remodeling, proteostatic regulation, and context-dependent control of reactive oxygen species (ROS). We further discuss mitochondrial genome and translational maintenance, fusion/fission dynamics, apoptotic susceptibility, and mitochondria-associated membrane (MAM) signaling as mechanisms through which mitochondrial function can be adjusted to environmental and therapeutic stress. Beyond tumor cells, we examine how mitochondrial quality-control alterations accompany systemic metabolic remodeling during cancer cachexia and how impaired mitophagy and intercellular mitochondrial transfer can influence antitumor T-cell function. These tumor–host manifestations are considered consequences or interacting mechanisms of cancer-associated mitochondrial remodeling rather than defining criteria of AMS. Finally, we discuss how context-dependent mitochondrial and redox dependencies may expose therapeutic vulnerabilities and provide a rationale for bioenergetic stratification in precision oncology.

1 January 2020 in eNeurobiología
Verified
Journal Article
Open access
PDF file
JRJESUS ANTONIO LARA REYES
JESUS ANTONIO LARA REYES
ALAlejandra Llanes-Duran
Alejandra Llanes-Duran
GAGonzalo Aranda-Abreu
Gonzalo Aranda-Abreu
MHMaria Elena Hernandez-Aguilar
Maria Elena Hernandez-Aguilar
FRFausto Rojas-Durán
Fausto Rojas-Durán
El trastorno del espectro autista (TEA) abarca un grupo complejo de trastornos del desarrollo neural que se caracterizan por presentar deficiencias en la interacción social, la comunicación y motricidad del individuo. El TEA tiene un impacto en la salud pública, por lo que sería de gran utilidad contar con biomarcadores que permitan la identificación temprana del trastorno. En este sentido, los microRNAs (miRNAs), que son reguladores de una gran variedad de funciones celulares y cuyas alteraciones en su expresión han sido observadas en individuos con TEA, se comienzan a considerar como blancos potenciales para el desarrollo de estrategias de diagnóstico y terapéuticas para estos trastornos. Esta revisión se enfoca en algunos estudios sobre la participación de miRNAs en el TEA, en modelos animales y humanos, y hace una aproximación a su posible uso como biomarcadores. The autism spectrum disorder (ASD) includes a complex group of neural development disorders that are characterized by deficiencies in social interaction, communication, and motor skills of individuals. ASD has an impact on public health, so it would be very useful to have biomarkers that allow early identification of the disorder. In this sense, microRNAs (miRNAs), which are regulators of a wide variety of cellular functions and whose alterations in their expression have been observed in individuals with ASD, are beginning to be considered as potential targets for the development of diagnostic and therapeutic strategies for these disorders. This review focuses on some studies about the participation of miRNAs in ASD in animal models, as well as in humans, and makes an approach to their possible use as biomarkers. Keywords: MicroRNAs; autism spectrum disorder; biomarker.

15 April 2026 in Frontiers in Medicine
Verified
Journal Article
Open access
PDF file
JRJESUS ANTONIO LARA REYES
JESUS ANTONIO LARA REYES
GAGonzalo Emiliano Aranda-Abreu
Gonzalo Emiliano Aranda-Abreu
XCXamanek Cortijo-Palacios
Xamanek Cortijo-Palacios
AAArnoldo Aquino-Gálvez
Arnoldo Aquino-Gálvez
MCManuel Castillejos-López
Manuel Castillejos-López
FRFausto Rojas-Durán
Fausto Rojas-Durán
Fibromyalgia is a complex, heterogeneous and often disabling syndrome that seriously affects the quality of life of patients. It is characterized by chronic widespread musculoskeletal pain, fatigue, sleep disturbances, and cognitive impairment. Its pathophysiology remains poorly understood, and conventional treatments often offer limited efficacy while carrying significant side effects, highlighting the urgent need for alternative therapeutics strategies. We report a retrospective case series evaluating a novel protocol that combines low frequency Pulsed Electromagnetic Field (PEMF) therapy, medical ozone insufflation, and targeted nutritional supplementation in three patients with refractory fibromyalgia who had previously shown inadequate response to conventional treatments. Following the intervention, patients experienced substantial pain relief and significant improvement in quality of life, which were sustained at the 30-day follow-up assessment. These findings suggest that the combination of PEMF and ozone therapy may induce durable physiological benefits, presenting a promising complementary strategy for managing refractory fibromyalgia.